🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Isabelle Lousada

Amyloidosis Foundation

ORCID: 0000-0002-3506-0359

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group”.

Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group

Patient Related Outcome Measures(2023)10.2147/prom.s399658

N/A

0DataRank · unranked

15 citations

Michelle K. White, Anita D’Souza, Kristen Hsu, Paula Schmitt, Tiffany P. Quock +4 more

Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings

Advances in Therapy(2024)10.1007/s12325-024-02891-0

N/A

0DataRank · unranked

7 citations

Prem Soman, Adrian F. Hernandez, Pablo García‐Pavía, James Signorovitch, L. J. Wei +54 more

Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis

Kidney International Reports(2024)10.1016/j.ekir.2024.03.033

N/A

0DataRank · unranked

4 citations

Raymond L. Comenzo, Julian D. Gillmore, Andrea Havasi, Efstathios Kastritis, Spencer Guthrie +7 more

Factors associated with financial toxicity in patients with transthyretin amyloidosis: results from Amyloidosis Research Consortium’s treatment affordability patient and caregiver survey

Amyloid(2025)10.1080/13506129.2025.2462541

N/A

0DataRank · unranked

3 citations

Kristen Hsu, José Nativi-Nicolau, Chafic Karam, Martha Grogan, Isabelle Lousada +2 more